Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YJ001 Spray for Diabetic Peripheral Neuropathic Pain
NCT07858344Phase 2Completed
- Sponsor
- Zhejiang Yuejia Pharmaceutical
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of YJ001 in diabetic polyneuropathy (DPN) (4 arms), sponsored by Zhejiang Yuejia Pharmaceutical. Primary endpoint: Numeric Rating Scale pain score at 12 weeks. Started Jan 2024; status: completed.
02
Drugs
YJ001
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT07858344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07858344.